These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11688717)

  • 1. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
    Schlehuber S; Skerra A
    Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
    Korndörfer IP; Beste G; Skerra A
    Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
    Schlehuber S; Beste G; Skerra A
    J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
    Vopel S; Mühlbach H; Skerra A
    Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
    Schlehuber S; Skerra A
    Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered protein scaffolds for molecular recognition.
    Skerra A
    J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties.
    Skerra A
    J Biotechnol; 2001 Jun; 74(4):257-75. PubMed ID: 11526907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
    Vogt M; Skerra A
    Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of ribosome display library based on lipocalin scaffold and screening anticalins with specificity for estradiol.
    Liu J; Ning B; Liu M; Sun Y; Sun Z; Zhang Y; Fan X; Zhou Z; Gao Z
    Analyst; 2012 May; 137(10):2470-9. PubMed ID: 22489281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies.
    Hohlbaum AM; Skerra A
    Expert Rev Clin Immunol; 2007 Jul; 3(4):491-501. PubMed ID: 20477155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticalins as alternative binding proteins for therapeutic use.
    Skerra A
    Curr Opin Mol Ther; 2007 Aug; 9(4):336-44. PubMed ID: 17694446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase.
    Kampmeier F; Ribbert M; Nachreiner T; Dembski S; Beaufils F; Brecht A; Barth S
    Bioconjug Chem; 2009 May; 20(5):1010-5. PubMed ID: 19388673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
    Richter A; Eggenstein E; Skerra A
    FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins".
    Schlehuber S; Skerra A
    Drug Discov Today; 2005 Jan; 10(1):23-33. PubMed ID: 15676296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid isolation of high-affinity protein binding peptides using bacterial display.
    Bessette PH; Rice JJ; Daugherty PS
    Protein Eng Des Sel; 2004 Oct; 17(10):731-9. PubMed ID: 15531628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered binding proteins as biosensors for fermentation and cell culture.
    Ge X; Tolosa L; Simpson J; Rao G
    Biotechnol Bioeng; 2003 Dec; 84(6):723-31. PubMed ID: 14595785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural tolerance of bacterial autotransporters for folded passenger protein domains.
    Veiga E; de Lorenzo V; Fernández LA
    Mol Microbiol; 2004 May; 52(4):1069-80. PubMed ID: 15130125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.